Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000638 |
Amiodarone |
Amiodarone results in decreased expression of TG mRNA | decreases expression | 18020914
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of TG mRNA | affects expression | 16483693
|
C095105 |
bexarotene |
bexarotene results in increased expression of TG mRNA | increases expression | 16648578
|
C055494 |
caffeic acid phenethyl ester |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in increased expression of TG mRNA | affects cotreatment|increases expression | 20360939
|
C014347 |
decitabine |
[decitabine co-treated with Tretinoin] results in increased expression of TG mRNA | affects cotreatment|increases expression | 19524134
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in increased expression of TG mRNA | affects cotreatment|increases expression | 20360939
|
D008713 |
Methimazole |
Methimazole results in decreased expression of TG protein | decreases expression | 17332529
|
C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in increased expression of TG mRNA | increases expression | 17616710
|
C494474 |
perchlorate |
perchlorate results in decreased expression of TG protein | decreases expression | 17332529
|
D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of TG mRNA | decreases expression | 18175754
|
D013974 |
Thyroxine |
Thyroxine inhibits the reaction [Thiourea results in increased expression of TG mRNA] | decreases reaction|increases expression | 17888916
|
D013890 |
Thiourea |
Thiourea results in increased expression of TG mRNA | increases expression | 17888916
|
D013890 |
Thiourea |
Thyroxine inhibits the reaction [Thiourea results in increased expression of TG mRNA] | decreases reaction|increases expression | 17888916
|
D014212 |
Tretinoin |
[decitabine co-treated with Tretinoin] results in increased expression of TG mRNA | affects cotreatment|increases expression | 19524134
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of TG mRNA | increases expression | 17679169
|
D014638 |
Vanadates |
Vanadates results in increased expression of TG protein | increases expression | 17874149
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.64 | 18287403 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
2.88 | 10737359 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
3.98 | 16434500 19052882 19061943 17162532 17620307 18056438 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.66 | 15955085 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Amiodarone |
3.85 | 20041841 18057881 18218290 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.11 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.27 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.36 | 16456186 |
MESH:D001281 |
Atrial Fibrillation |
|
Amiodarone |
3.94 | 18651412 19698954 |
OMIM:608175 |
AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3 |
marker/mechanism |
|
| |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.47 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Amiodarone |
9.44 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
9.44 | 16197459 16206674 |
MESH:D001943 |
Breast Neoplasms |
|
bexarotene |
2.02 | 16818667 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.02 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.02 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.02 | 16443354 16873071 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.67 | 16813970 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.26 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
3.06 | 18978308 19701751 18691550 20524982 16935385 19052882 16569478 17978847 16540662 20007298 10737359 17173139 19107877 16288022 18494052 19171122 20214788 19394651 19383236 10672840 18056438 17138121 19208518 20084675 19919837 19539802 16698587 20935162 18971187 3581430 16830150 19335982 16681979 3084413 20101231 17055752 17162532 21159647 18665156 16779866 20512989 16502159 20432363 17761372 19418558 18210153 18506893 11831363 16878318 16328049 17428255 19822196 18788625 20727157 19519916 18785209 20514400 16807293 18393292 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
3.06 | 1917145 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
bexarotene |
3.24 | 16247446 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
4.81 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.81 | 16051514 16096774 |
MESH:D006332 |
Cardiomegaly |
|
Thyroxine |
4.13 | 18093424 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Amiodarone |
2.91 | 19225199 15710769 |
MESH:D002341 |
Carotid Artery Thrombosis |
|
Amiodarone |
5.17 | 18974383 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.12 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
2.89 | 7505956 21159647 17174075 2727394 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.67 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
3.73 | 19052882 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.26 | 16461808 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.82 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.69 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.78 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.34 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
1.82 | 9224671 17551590 16925845 9664655 9211117 8800419 9142499 10589399 14991402 9125849 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.82 | 16285004 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
2.20 | 20387270 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Amiodarone |
6.42 | 15265979 18218290 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
6.42 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
6.42 | 15131321 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.56 | 18230668 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.21 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.14 | 16569247 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.21 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
2.79 | 16510608 15264214 15547733 15547721 16805852 16704527 15150132 15623463 15878914 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.62 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
Amiodarone |
8.14 | 14986274 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
8.14 | 21071580 20387270 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
3.58 | 17994277 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.04 | 17312396 |
MESH:D006042 |
Goiter |
marker/mechanism |
|
| 8094490 |
MESH:D006042 |
Goiter |
|
perchlorate |
5.36 | 18801409 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
7.95 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
7.95 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.26 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
2.92 | 9664655 14991402 |
MESH:D006529 |
Hepatomegaly |
|
Amiodarone |
3.82 | 15265979 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.25 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
Amiodarone |
3.93 | 8137927 9751232 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.64 | 16778211 |
MESH:D006980 |
Hyperthyroidism |
|
Methimazole |
5.68 | 14678291 |
MESH:D007037 |
Hypothyroidism |
|
Amiodarone |
12.06 | 18020914 17991464 |
MESH:D007037 |
Hypothyroidism |
|
Methimazole |
12.06 | 18031379 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
3.24 | 17581917 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
2.40 | 18785209 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
3.31 | 14714311 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.84 | 17994277 |
MESH:D007414 |
Intestinal Neoplasms |
|
caffeic acid phenethyl ester |
4.64 | 10783313 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
3.95 | 17551590 15992940 |
MESH:D007674 |
Kidney Diseases |
|
caffeic acid phenethyl ester |
3.58 | 15369732 |
MESH:D007938 |
Leukemia |
|
decitabine |
6.51 | 18980019 19235587 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
6.51 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
9.75 | 18454857 19117987 17236224 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
9.75 | 16932348 19285840 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
4.00 | 19010910 18460780 19387464 17679729 18206229 18704418 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
4.00 | 17596541 19850784 16294345 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.56 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
caffeic acid phenethyl ester |
8.03 | 16766008 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
8.03 | 19075265 17217047 17294898 16935935 16823087 16766008 16788101 17506722 16891316 16331271 17361223 9834237 17649720 15748426 12679006 19225113 16140955 17339181 17712046 19035177 17107899 19642359 17301526 19029980 17368321 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.34 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Amiodarone |
3.55 | 15342952 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.85 | 18407596 20032147 18522880 18665156 19638242 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
1.80 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.11 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
2.26 | 15175105 19499222 15885732 19812893 20583210 10737359 19850985 19294768 21071580 19690152 20434301 19833225 2862719 18644402 18977376 12771043 18648771 21047994 19090486 20137499 20118626 12112319 21167192 19073162 19254457 19256749 19642983 21278145 2422723 20452335 19427195 19426721 19996281 18754104 18978307 9163691 20501860 16942905 20101389 19638242 19551842 20492335 19255062 20405173 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
2.66 | 18253720 19009564 19519916 19126423 16842330 18544905 17174075 18079962 18164116 17942915 9362446 19539802 18282651 18775883 2563599 18093689 19004024 16267830 21159647 3124819 17854601 18308698 |
MESH:D008133 |
Long QT Syndrome |
|
Amiodarone |
3.62 | 17391786 11989578 15350150 |
MESH:D008171 |
Lung Diseases |
|
Amiodarone |
3.41 | 12587719 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Amiodarone |
4.58 | 18516814 |
MESH:D008175 |
Lung Neoplasms |
|
bexarotene |
2.74 | 17849452 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
2.74 | 20970405 20512841 21163286 6695378 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.46 | 19470736 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.12 | 14737004 |
MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
bexarotene |
5.22 | 11161223 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
bexarotene |
3.44 | 19196722 19196723 15591091 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.80 | 17453147 |
MESH:D008545 |
Melanoma |
|
decitabine |
3.45 | 16505122 17785578 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
3.45 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.50 | 16940565 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.38 | 18172295 |
MESH:D009181 |
Mycoses |
|
Amiodarone |
5.00 | 12754197 17974566 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
7.58 | 16882708 19157545 19010910 18608210 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.58 | 17596541 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.59 | 3581430 9029167 |
MESH:D009369 |
Neoplasms |
|
decitabine |
5.27 | 17925555 19470736 19116145 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
5.27 | 16594593 16946489 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
bexarotene |
4.88 | 19196722 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
3.84 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.09 | 9142499 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.39 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.21 | 20387270 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
5.01 | 19331143 19259094 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
5.01 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.95 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
8.75 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
8.75 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
8.75 | 15976015 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.60 | 2563599 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.80 | 17616702 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.39 | 18760546 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.66 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.88 | 16723453 |
MESH:D011654 |
Pulmonary Edema |
|
Thiourea |
6.01 | 10849556 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Amiodarone |
2.87 | 11597910 12490602 12832656 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
11.15 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
11.15 | 16116481 16283617 |
OMIM:609620 |
SHORT QT SYNDROME 1 |
|
Amiodarone |
5.17 | 18724381 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
2.63 | 16467112 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
4.80 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
4.80 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
4.80 | 17575124 12958204 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
4.80 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Amiodarone |
3.37 | 18087811 |
MESH:D013610 |
Tachycardia |
|
Amiodarone |
4.35 | 11238279 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Amiodarone |
4.25 | 19225199 |
MESH:D013959 |
Thyroid Diseases |
|
Amiodarone |
13.02 | 19731979 |
MESH:D013959 |
Thyroid Diseases |
|
Thyroxine |
13.02 | 19910387 |
OMIM:274700 |
THYROID DYSHORMONOGENESIS 3 |
marker/mechanism |
|
| |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
12.26 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
12.26 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
12.26 | 17045167 16026305 |
MESH:D013971 |
Thyrotoxicosis |
|
Amiodarone |
4.93 | 18020914 19584973 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.84 | 16051514 |
MESH:D016171 |
Torsades de Pointes |
|
Amiodarone |
4.27 | 11989578 17467628 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.26 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
2.74 | 17616700 19087683 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.73 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
13.16 | 17785578 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
13.16 | 16752155 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.12 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.02 | 16287080 |